Marco Pirisinu: Highlights Potential of PDEVs in Drug Delivery
Marco Pirisinu, Director of Business Development at Jotbody, shared a post on LinkedIn:
“Hey everyone,
I recently came across a review discussing the potential of plant-derived extracellular vesicles (PDEVs) in drug delivery.
Some highlights:
• Natural Carriers: PDEVs naturally encapsulate bioactive molecules like proteins, lipids, and RNAs, which can synergize with therapeutic agents.
• Biocompatibility: Being plant-based, they exhibit low immunogenicity, reducing potential adverse reactions.
• Stability: PDEVs demonstrate resilience under various conditions, ensuring the integrity of encapsulated drugs.
• Scalability: Plants offer a sustainable and scalable source for vesicle production, facilitating large-scale applications.
These attributes make PDEVs a promising avenue for delivering a range of therapeutic agents, including small molecules, proteins, and nucleic acids.
I will also put the reference here“.
All the latest news in the World of Hematology featured in Hemostasis Today.
-
Jan 15, 2026, 15:09Louise St Germain Bannon: ISTH Education is Off to An Exciting Start in 2026
-
Jan 15, 2026, 13:12Michele Romoli: What is The Optimal Treatment Strategy After Stroke While on DOAC?
-
Jan 15, 2026, 12:18Isabelle Mahé on Reduced Dose Apixaban and Cancer-Associated VTE
-
Jan 15, 2026, 04:52Lucien Blondel on Resolve Stroke: To Be Used In the SCULPT Trial
-
Jan 15, 2026, 04:40Mitchell Elkind: Mental Disorders, Brain Health, and Acute Coronary Syndrome
-
Jan 15, 2026, 04:31Laura Dormer on Comparing Stroke Care in Medicare Advantage Versus Fee-for-Service
-
Jan 14, 2026, 21:15Cihan Ay Congratulates Cornelia Englisch on Successful Completion of Her PHD
-
Jan 14, 2026, 20:53Ana Sachetto on Reporting Negative Results
-
Jan 14, 2026, 16:22Leo Nicolai and Rainer Kaiser Link Procoagulant Platelets and Thromboinflammation in CVD